These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prophylaxis and treatment of infection in the bone marrow transplant recipient. Winston DJ Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916 [TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus infection after bone marrow transplantation in children. Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440 [TBL] [Abstract][Full Text] [Related]
26. [Prevention of cytomegalovirus pneumonia in patients with adult T-cell leukemia by nested PCR monitoring]. Ohtsuka E; Uno N; Ogata M; Ohno E; Hirota K; Tezono K; Tokimatsu I; Kikuchi H; Nasu M Gan To Kagaku Ryoho; 1998 Aug; 25(10):1609-11. PubMed ID: 9725057 [No Abstract] [Full Text] [Related]
27. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. Snydman DR Clin Transplant; 1995 Dec; 9(6):490-1. PubMed ID: 8645893 [No Abstract] [Full Text] [Related]
28. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Atkinson K; Nivison-Smith I; Dodds A; Concannon A; Milliken S; Downs K Bone Marrow Transplant; 1998 Apr; 21(7):691-5. PubMed ID: 9578309 [TBL] [Abstract][Full Text] [Related]
29. [The use of hyperimmune anti-cytomegalovirus immunoglobulins in HIV infection]. Mancuso S; Abbadessa V; Perricone R; Cajozzo A Recenti Prog Med; 1996 Jun; 87(6):267-70. PubMed ID: 8766951 [TBL] [Abstract][Full Text] [Related]
36. Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant. Prentice HG; Kho P Bone Marrow Transplant; 1997 Jan; 19(2):135-42. PubMed ID: 9116610 [TBL] [Abstract][Full Text] [Related]
37. [Use of intravenous immunoglobulin preparations in chronic lung diseases]. Jankowska R Postepy Hig Med Dosw; 2002; 56 Suppl():49-52. PubMed ID: 12661414 [TBL] [Abstract][Full Text] [Related]
38. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation. Szer J; Durrant S; Schwarer AP; Bradstock KF; Gibson J; Arthur C; To LB; Hughes T; Raunow H Intern Med J; 2004 Mar; 34(3):98-101. PubMed ID: 15030456 [TBL] [Abstract][Full Text] [Related]
39. Clinical aspects and management of cytomegalovirus infection. Sissons JG; Carmichael AJ J Infect; 2002 Feb; 44(2):78-83. PubMed ID: 12076065 [TBL] [Abstract][Full Text] [Related]
40. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]